Institute of Human Virology Annual Meeting 2005-2010

人类病毒学研究所2005-2010年年会

• 批准号: 7087025
• 负责人: ROBERT C GALLO
• 金额: $ 4.6万
• 依托单位: UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-18 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7087025
• 关键词: AIDS; AIDS related neoplasm /cancer; health science research potential; information dissemination; meeting /conference /symposium; minority health professional; travel

For nine years the International Meeting of the Institute of Human Virology (Meeting) has provided a forum for dedicated scientists in the fields of virology, most specifically HIV/AIDS and cancer biology to present new data and exchange ideas and views. The Meeting serves as a unique conference with the following aims: 1. To disseminate the most current research findings within the selected program topics; 2. To critically assess the impact of new findings on future directions for research; 3. To provide a forum for discussion of current and emerging issues; 4. To identify, support, and build the next generation AIDS researcher; 5. To increase participation by women ethnic/racial minorities, and other individuals who have been traditionally under represented in science, yet over represented in the populations impacted most by the disease and to increase participation by individuals from the developing world. The Institute of Human Virology (EHV), with the financial support requested in this application, will accomplish these aims: a) by attracting world renown senior scientists as presenters and participants; b) by carefully organizing each dedicated conference session with theoretically divergent perspectives and ethnically diverse participants; c) by enriching the scientific sessions with an open schedule to foster dialog and interaction between and among investigators; d) by reaching out to and promoting the participation of young investigators in poster sessions and scholarship initiatives, and e) by ensuring that conference results are shared with the broader scientific community through publication of all speaker and poster abstracts. The Meeting is further strengthened by a strictly enforced press policy, one that protects data presented at the Meeting for future peer-reviewed publication. This policy prohibits the members of the press from disclosing any information presented at the Annual Meeting without the permission of the presenter. An estimated 650 scientists and clinicians from around the world are expected to participate in this five-day meeting scheduled for August 29 - September 2, 2005 at the Baltimore Waterfront Marriott. To increase participation by FDA and NIH scientists the meetings in 2006-2009 will be alternate between Bethesda and Baltimore in suitable locations. The Meeting for 2005 will offer a combination of single track and dual track lectures. The incorporation of dual track sessions is a result of feedback from our participants who like some of the more specialized sessions that may not be of interest to the entire group but may not be topics at more general meetings they attend including topics like HTLV. This change also allows for more time to be set aside for oral presentations selected from a call for abstracts. Each conference session opens with a senior scientist's overview presentation on the current base of knowledge in the topic of discussion. This overview provides a basis for evaluation of the data presented by a panel of speakers, each sharing the results of their work. The Annual Meeting Program Committee, responsible for the program content, is encouraged to invite speakers with differing perspectives to stimulate open discussion. Posters are displayed throughout the meeting. One evening is set aside for a reception in the poster area to encourage attendance and interaction. Evening social events are provided to encourage participants to meet with current and potential collaborators, and to talk with presenters. The Annual Meeting Scholarship Initiative provides funds to ensure the participation of promising women, ethnic and racial minorities, and other individuals who have been traditionally underrepresented in science as well as participants from the developing world.

九年来，人类病毒学研究所的国际会议（会议）为病毒学领域的专门科学家提供了一个论坛，最具体地说是艾滋病毒/艾滋病和癌症生物学，以提出新的数据以及交流思想和观点。会议是一个独特的会议，其目的是： 1。在选定的程序主题中传播最新的研究结果； 2。批判性地评估新发现对未来研究方向的影响； 3。提供一个论坛，讨论当前和新兴问题； 4。确定，支持和建立下一代艾滋病研究人员； 5。增加妇女/种族少数群体的参与，以及传统上在科学中表现不佳的其他人的参与，但在受疾病影响最大的人群中过度代表，并增加了发展中国家的个人参与。 人类病毒学研究所（EHV）在本申请中要求的财政支持将实现这些目标：a）通过吸引世界知名的高级科学家作为主持人和参与者； b）通过仔细组织每个专门的会议会议，理论上有分歧和种族不同的参与者； c）通过开放的时间表来培养调查人员之间和之间的互动，以丰富科学会议； d）通过与年轻调查人员的参与并促进海报会议的参与并促进 奖学金计划，以及e）通过发布所有演讲者和海报摘要，确保会议结果与更广泛的科学界共享。严格执行的新闻政策进一步加强了会议，该政策保护会议上提供的数据以供未来的同行评审出版物。该政策禁止新闻界成员未经 主持人。估计有650名来自世界各地的科学家和临床医生预计将参加计划于2005年8月29日至9月2日在巴尔的摩滨水区的为期五天的会议。为了增加FDA和NIH科学家的参与，2006 - 2009年的会议将在合适的位置进行贝塞斯达和巴尔的摩之间的替代。 2005年的会议将提供单轨和双轨道讲座的结合。双重轨道会议的结合是我们参与者的反馈结果，他们喜欢一些更专业的会议，这些会议可能对整个小组不感兴趣，但可能不是他们参加的更多广告会议的主题，包括HTLV等主题。这 更改还允许为从摘要的调用中选择的口头演示留出更多时间。每次会议都在讨论主题中有关当前知识基础的高级科学家的概述介绍开始。此概述为评估一组演讲者提供的数据提供了基础，每个人都共享其工作结果。鼓励负责该计划内容的年度会议计划委员会 邀请具有不同观点的演讲者刺激公开讨论。在整个会议期间都显示海报。一个晚上预留在海报区域的接待处，以鼓励出席和互动。提供晚间的社交活动，以鼓励参与者与当前和潜在的合作者会面，并与主持人交谈。年度会议奖学金倡议提供资金，以确保有前途的妇女，种族和种族少数群体以及其他传统上人数不足的人以及来自发展中国家的参与者的参与。